Skip to main content
Clinical Trials/NCT04931550
NCT04931550
Recruiting
Not Applicable

Clinical Study of Impact of Different Pacing Site in Patients

Second Affiliated Hospital, School of Medicine, Zhejiang University1 site in 1 country600 target enrollmentAugust 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Bradyarrhythmias
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Enrollment
600
Locations
1
Primary Endpoint
Composite of Cardiovascular death, myocardial infarction, and stroke events
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

At present, cardiac pacing has been widely used in the treatment of bradyarrhythmias and heart failure, which can effectively improve the survival rate of patients. With the rapid development of technology, different sites can be chosen to pace, such as right atrial appendage, the atrial septum and the right atrial wall in the atrium, His bundle, left bundle branch area, right ventricular apex, outflow tract, and left ventricular pacing via coronary vein in the ventricle. There are few studies comparing the long-term efficacy and safety of different pacing sites in daily practice. This study aims to observe the efficacy and safety of cardiac pacing at different sites in short and long term, and to compare the advantages and disadvantages of pacing at different sites.

Registry
clinicaltrials.gov
Start Date
August 1, 2020
End Date
December 2026
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients who received pacemaker implantation in the Second Hospital of Zhejiang Medical University by Pan Xiaohong and other surgeons.
  • Patients who have the ability to understand the test and can cooperate with investigators.

Exclusion Criteria

  • Patients who unable to understand or unwilling to fill in informed consent forms or follow visitors.

Outcomes

Primary Outcomes

Composite of Cardiovascular death, myocardial infarction, and stroke events

Time Frame: 60 months

Composite of Cardiovascular death, myocardial infarction, and stroke events in 60 months

Study Sites (1)

Loading locations...

Similar Trials